Search results
Showing 1 to 15 of 21 results for anaemia ckd
Roxadustat for treating symptomatic anaemia in chronic kidney disease (TA807)
Evidence-based recommendations on roxadustat (Evrenzo) for treating symptomatic anaemia associated with chronic kidney disease in adults.
This guideline covers care and treatment for people with, or at risk of, chronic kidney disease (CKD). It aims to prevent or delay the progression, and reduce the risk of complications and cardiovascular disease. It also covers managing anaemia and hyperphosphataemia associated with CKD.
In development [GID-TA10877] Expected publication date: 20 November 2024
NG203/13 Question Managing anaemia: For adults, children and young people with CKD and anaemia, what is the...
Management of anaemia of CKD with concurrent illness: What is the optimal management (in terms of clinical and cost...
NG203/14 Question Managing anaemia: For adults, children and young people with CKD and anaemia who are on...
Recommendation ID NG203/4 Question Managing anaemia – optimal Hb levels for children and young people: What is the efficacy and safety
Managing anaemia: What are the long-term consequences of high ferritin levels (above 800 micrograms/litre) in children and young people...
Renal replacement therapy and conservative management (NG107)
This guideline covers renal replacement therapy (dialysis and transplantation) and conservative management for people with chronic kidney disease stages 4 and 5. It aims to improve quality of life by making recommendations on planning, starting and switching treatments, and coordinating care.
This guideline covers the assessment for and management of blood transfusions in adults, young people and children over 1 year old. It covers the general principles of blood transfusion, but does not make recommendations relating to specific conditions.
Evidence-based recommendations on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis
duration of intravenous iron preparations in children with anaemia of chronic kidney disease (CKD), including...
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
Daprodustat for treating anaemia in people with chronic kidney disease [ID3987]
In development [GID-TA10886] Expected publication date: TBC
Voxelotor for treating haemolytic anaemia caused by sickle cell disease (TA981)
Evidence-based recommendations on voxelotor (Oxbryta) for haemolytic anaemia caused by sickle cell disease in people 12 years and over.